THROMBIN GENERATION TEST IN PATIENTS UNDER NEW ORAL ANTICOAGULANTS (DABIGATRAN AND RIVAROXABAN)

被引：0
|
作者：
Cabrera, N. [1 ]
Moret, A. [1 ]
Mesa, E. [1 ]
Vila, V. [1 ]
Mira, Y. [1 ]
Ferrando, F. [1 ]
Aznar, Jose A. [1 ]
Bonanad, S. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Unidad Hemostasia & Trombosis, Valencia, Spain
来源：
THROMBOSIS RESEARCH | 2014年 / 133卷
关键词：
D O I：
10.1016/S0049-3848(14)50148-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C0416
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [1] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Heard, L. Kevin
    Shanahan, Christine
    Maggio, Kurt L.
    DERMATOLOGIC SURGERY, 2017, 43 (04) : 597 - 599
  • [2] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Chang, Timothy W.
    Arpey, Christopher J.
    Baum, Christian L.
    Brewer, Jerry D.
    Hochwalt, Phillip C.
    Hocker, Thomas L.
    Roenigk, Randall K.
    Otley, Clark C.
    DERMATOLOGIC SURGERY, 2015, 41 (07) : 784 - 793
  • [3] Emergency surgery and trauma in patients treated with the new oral anticoagulants: Dabigatran, rivaroxaban, and apixaban
    Moorman, Matthew L.
    Nash, Joshua E.
    Stabi, Katie L.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (03): : 486 - 494
  • [4] Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Jorn D.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2017, 1 (02) : 194 - 201
  • [5] New anticoagulants: dabigatran, rivaroxaban and apixaban
    Vargas Ruiz, Angel Gabriel
    Ramirez Lopez, Alba Nydia
    Medina Viramontes, Monica Elizabeth
    GACETA MEDICA DE MEXICO, 2012, 148 (03): : 257 - 264
  • [6] Evaluation of Assay Performance Monitoring the New Oral Anticoagulants Rivaroxaban and Dabigatran
    Wagner, Lieselotte
    Leitner, Martina
    Kaufmann, Viktoria
    Mager, Jutta
    BLOOD, 2012, 120 (21)
  • [7] SYSTEMATIC ASSESSMENT OF THE EFFECT OF DIRECT ORAL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN USING CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY IN VIVO
    Artang, Ramin
    Anderson, Maren
    Riley, Paul
    Nielsen, Joern Dalsgaard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 768 - 768
  • [8] Novel Oral Anticoagulants in Development: Dabigatran, Rivaroxaban, and Apixaban
    Sattari, Maryam
    Lowenthal, David T.
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (04) : 332 - 338
  • [9] Laboratory monitoring of novel oral anticoagulants rivaroxaban and dabigatran
    Eerenberg, E. S.
    Kamphuisen, P. W.
    Sijpkens, M. K.
    Meijers, J. C.
    Buller, H. R.
    Levi, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 956 - 956
  • [10] A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban)
    Lv, Meina
    Jiang, Shaojun
    Wu, Tingting
    Huang, Nianxu
    Chen, Xia
    Chen, Chunmei
    Zhang, Jinhua
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 253 - 260
12345